Category Archives: Pharmaceuticals

Featured Stories
Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Lawsuits Allege Abilify Caused Impulse-Control Problems

Lawsuits Allege Abilify Caused Impulse-Control Problems

Abilify Lawsuits Allege Gambling Addiction, Compulsive Behaviors Bristol-Myers Squibb and Otsuka Pharmaceuticals are facing lawsuits alleging that the antipsychotic medication Abilify caused impulse-control problems, including pathological gambling. Litigation continues to mount as cases are consolidated into a federal multidistrict litigation … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Serious Brain Side Effects of Dilantin

Epilepsy patients who take the drug Dilantin to control seizures could experience a variety of side effects, including atrophy of the cerebellum, an area of the brain important to the control of movement and coordination. Posture, balance, coordination and speech … Continue reading

Posted in Dilantin, Health Concerns, Pharmaceuticals |

Lawsuit Alleges Xarelto Led to Ischemic Stroke

Xarelto Lawsuits Continue to Mount Over Bleeding Injuries Bayer Healthcare AG, Johnson & Johnson, and Janssen Pharmaceuticals are facing a wrongful death lawsuit over allegations that their anticoagulant (blood thinner), Xarelto (rivaroxaban) led to a West Virginia man’s ischemic stroke … Continue reading

Posted in Pharmaceuticals |

Invega Linked to Serious Side Effects Such As Gynecomastia

Invega Linked to Serious Side Effects Such As Gynecomastia

Invega is a popular antipsychotic medication increasingly associated with serious side effects such as gynecomastia, or male breast growth. Invega, known also by its generic name, paliperidone, is manufactured and distributed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Propecia Litigation Moving Toward First Trial

The litigation involving serious and sometimes catastrophic side effects of the hair loss drug Propecia is moving forward, with the selection of bellwether cases. In such large litigations, representative cases—bellwether cases—are chosen to be the first to go to trial. … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Propecia, Proscar |

Depakote Anti-Epilepsy Medication Linked to Birth Defects

Depakote Anti-Epilepsy Medication Linked to Birth Defects

The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged , , , , |

Estrogen Product Premarin Tablets Recalled due to Labeling Issues

Estrogen Product Premarin Recalled due to Labeling Issues

Pfizer, the maker of Premarin, announced a voluntary recall of one lot of 1.25mg tablets due to an incorrect expiration date on the bottle label. What is Premarin? Premarin is an estrogen product commonly used to treat moderate to severe … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Controversial Diabetes Drug Actos Still on the Market

Controversial Diabetes Drug Actos Still on the Market

Though research has shown an association between the type 2 diabetes drug Actos and serious side effects including bladder cancer, heart failure, liver failure, and bone fractures, the Food and Drug Administration (FDA) has stopped short of recalling Actos. Actos … Continue reading

Posted in Actos, Pharmaceuticals | Tagged , , , , |

Clash Over Regulation of “Off-Label” Promotion of Drugs and Devices

Clash Over “Off-Label” Promotion of Drugs and Devices

A 2012 decision from the U.S. Court of Appeals for the Second Circuit that reversed the conviction of Alfred Caronia, a drug representative accused of conspiring to promote the drug Xyrem for unapproved uses set up a clash between the … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Antidepressant Viibryd to Carry Warning for Acute Pancreatitis, Sleep Paralysis

Viibryd Now Warns for Acute Pancreatitis, Sleep Paralysis

Viibryd (Vilazodone) Safety Label to Include Sleep Paralysis, Acute Pancreatitis Viibryd (vilazodone) is a selective serotonin reuptake inhibitor (SSRI) manufactured by Forest Laboratories. According to a recent letter from the U.S. Food and Drug Administration (FDA), the warning label on … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.